<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Development of acute lymphoblastic leukemia following hemophagocytic lymphohistiocytosis : is it secondary leukemia?</dc:title>
  <dc:creator>SUZUKI, T</dc:creator>
  <dc:creator>MUGISHIMA, H</dc:creator>
  <dc:creator>YAMADA, A</dc:creator>
  <dc:creator>NAGATA, T</dc:creator>
  <dc:creator>SHICHINO, H</dc:creator>
  <dc:creator>CHIN, M</dc:creator>
  <dc:creator>IMASHUKU, S</dc:creator>
  <dc:creator>HARADA, K</dc:creator>
  <dc:relation>International journal of hematology -- Int. j. hematol, ISSN 0925-5710, Vol. 70 (1) , pp. 58-59</dc:relation>
  <dc:date>1999</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Springer</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>10 ref</dc:format>
  <dc:subject xml:lang="fr">Enzyme</dc:subject>
  <dc:subject xml:lang="fr">Histiocytose</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hémopathie maligne</dc:subject>
  <dc:subject xml:lang="fr">Hémopathie</dc:subject>
  <dc:subject xml:lang="fr">Isomerases</dc:subject>
  <dc:subject xml:lang="fr">Lymphoprolifératif syndrome</dc:subject>
  <dc:subject xml:lang="fr">Aigu</dc:subject>
  <dc:subject xml:lang="fr">Anticancéreux</dc:subject>
  <dc:subject xml:lang="fr">Antimitotique</dc:subject>
  <dc:subject xml:lang="fr">Association médicamenteuse</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Corticostéroïde</dc:subject>
  <dc:subject xml:lang="fr">DNA topoisomerase (ATP-hydrolysing)</dc:subject>
  <dc:subject xml:lang="fr">Dexaméthasone</dc:subject>
  <dc:subject xml:lang="fr">Enfant</dc:subject>
  <dc:subject xml:lang="fr">Etoposide</dc:subject>
  <dc:subject xml:lang="fr">Etude cas</dc:subject>
  <dc:subject xml:lang="fr">Femelle</dc:subject>
  <dc:subject xml:lang="fr">Glucocorticoïde</dc:subject>
  <dc:subject xml:lang="fr">Hémophagocytose syndrome</dc:subject>
  <dc:subject xml:lang="fr">Inhibiteur enzyme</dc:subject>
  <dc:subject xml:lang="fr">Leucémie lymphoblastique</dc:subject>
  <dc:subject xml:lang="fr">Lymphohistiocytose hémophagocytique</dc:subject>
  <dc:subject xml:lang="fr">Podophyllotoxine dérivé</dc:subject>
  <dc:subject xml:lang="fr">Second cancer</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Enzyme</dc:subject>
  <dc:subject xml:lang="en">Histiocytosis</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Malignant hemopathy</dc:subject>
  <dc:subject xml:lang="en">Hemopathy</dc:subject>
  <dc:subject xml:lang="en">Isomerases</dc:subject>
  <dc:subject xml:lang="en">Lymphoproliferative syndrome</dc:subject>
  <dc:subject xml:lang="en">Acute</dc:subject>
  <dc:subject xml:lang="en">Antineoplastic agent</dc:subject>
  <dc:subject xml:lang="en">Antimitotic</dc:subject>
  <dc:subject xml:lang="en">Drug combination</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Corticosteroid</dc:subject>
  <dc:subject xml:lang="en">DNA topoisomerase (ATP-hydrolysing)</dc:subject>
  <dc:subject xml:lang="en">Dexamethasone</dc:subject>
  <dc:subject xml:lang="en">Child</dc:subject>
  <dc:subject xml:lang="en">Etoposide</dc:subject>
  <dc:subject xml:lang="en">Case study</dc:subject>
  <dc:subject xml:lang="en">Female</dc:subject>
  <dc:subject xml:lang="en">Glucocorticoid</dc:subject>
  <dc:subject xml:lang="en">Hemophagocytic syndrome</dc:subject>
  <dc:subject xml:lang="en">Enzyme inhibitor</dc:subject>
  <dc:subject xml:lang="en">Acute lymphocytic leukemia</dc:subject>
  <dc:subject xml:lang="en">Hemophagocytic lymphohistiocytosis</dc:subject>
  <dc:subject xml:lang="en">Podophyllotoxine derivatives</dc:subject>
  <dc:subject xml:lang="en">Second cancer</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Enzima</dc:subject>
  <dc:subject xml:lang="es">Histiocitosis</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hemopatía maligna</dc:subject>
  <dc:subject xml:lang="es">Hemopatía</dc:subject>
  <dc:subject xml:lang="es">Isomerases</dc:subject>
  <dc:subject xml:lang="es">Linfoproliferativo síndrome</dc:subject>
  <dc:subject xml:lang="es">Agudo</dc:subject>
  <dc:subject xml:lang="es">Anticanceroso</dc:subject>
  <dc:subject xml:lang="es">Antimitótico</dc:subject>
  <dc:subject xml:lang="es">Asociación medicamentosa</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Corticoesteroide</dc:subject>
  <dc:subject xml:lang="es">DNA topoisomerase (ATP-hydrolysing)</dc:subject>
  <dc:subject xml:lang="es">Dexametasona</dc:subject>
  <dc:subject xml:lang="es">Niño</dc:subject>
  <dc:subject xml:lang="es">Etopósido</dc:subject>
  <dc:subject xml:lang="es">Estudio caso</dc:subject>
  <dc:subject xml:lang="es">Hembra</dc:subject>
  <dc:subject xml:lang="es">Glucocorticoide</dc:subject>
  <dc:subject xml:lang="es">Hemofagocitosis síndrome</dc:subject>
  <dc:subject xml:lang="es">Inhibidor enzima</dc:subject>
  <dc:subject xml:lang="es">Leucemia linfoblástica</dc:subject>
  <dc:subject xml:lang="es">Linfohistiocitosis hemofagocitica</dc:subject>
  <dc:subject xml:lang="es">Podofilotoxina derivado</dc:subject>
  <dc:subject xml:lang="es">Segundo cáncer</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B19B: Leucémies. Lymphomes malins. Réticuloses malignes. Hématodermies. Splénomégalie myéloïde / Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1284437</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>